180 related articles for article (PubMed ID: 16174177)
1. Interpreting the improved outcome of patients with central nervous system metastases managed in clinical trials compared with standard hospital practice.
Tang JI; Back M; Shakespeare T; Lu JJ; Mukherjee R; Wynne C; Liang S
Australas Radiol; 2005 Oct; 49(5):390-5. PubMed ID: 16174177
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
3. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
4. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
[TBL] [Abstract][Full Text] [Related]
8. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
Nieder C; Pawinski A; Balteskard L
Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
[TBL] [Abstract][Full Text] [Related]
11. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
12. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Pectasides D; Aravantinos G; Fountzilas G; Kalofonos C; Efstathiou E; Karina M; Pavlidis N; Farmakis D; Economopoulos T; Dimopoulos MA
Anticancer Res; 2005; 25(5):3553-8. PubMed ID: 16101179
[TBL] [Abstract][Full Text] [Related]
13. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
14. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis.
Rades D; Kieckebusch S; Haatanen T; Lohynska R; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1319-24. PubMed ID: 18374222
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
[TBL] [Abstract][Full Text] [Related]
17. Selection of patients with melanoma brain metastases for aggressive treatment.
Harrison BE; Johnson JL; Clough RW; Halperin EC
Am J Clin Oncol; 2003 Aug; 26(4):354-7. PubMed ID: 12902884
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients with brain metastases.
Lagerwaard FJ; Levendag PC
Forum (Genova); 2001; 11(1):27-46. PubMed ID: 11734862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
